Viruses such as HPV (Human Papillomavirus) can cause persistent infections with oncogenic potential, which may progress to dysplasia. Current therapies are often unable to completely eradicate these infections, increasing the risk of cellular abnormalities, including malignant transformation. Libera Biotech is redefining the therapeutic landscape with nanotechnology-based antiviral treatments designed to effectively treat and protect against HPV-related infections.

At the core of the company’s innovation is a proprietary formulation and manufacturing process based on plant-derived nanovesicles – natural carriers of highly effective antioxidants. These bioactive compounds are capable of acting on the biological mechanisms involved in cellular degeneration.

The nanovesicles are extracted from plants through proprietary physical separation and concentration processes, resulting in a nanoconcentrate that preserves 100% of the active compounds found in the original plant. The isolated phytocomplex is immediately bioavailable, enabling efficient absorption by the body. At Libera Biotech, nature inspires science – a distinctive approach that makes the company Naturally Innovative.